Blocking of p38 and transforming growth factor β receptor pathways impairs the ability of tolerogenic dendritic cells to suppress murine arthritis
Author
dc.contributor.author
Gárate, David
Author
dc.contributor.author
Rojas Colonelli, Nicole
Author
dc.contributor.author
Peña, Corina
Author
dc.contributor.author
Salazar, Lorena
Author
dc.contributor.author
Abello, Paula
Author
dc.contributor.author
Pesce Reyes, Bárbara
Author
dc.contributor.author
Aravena, Octavio
Author
dc.contributor.author
García González, Paulina
Author
dc.contributor.author
Hager Ribeiro, Carolina
Author
dc.contributor.author
Molina, María C.
Author
dc.contributor.author
Catalán Martina, Diego
Author
dc.contributor.author
Aguillón Gutiérrez, Juan Carlos
Admission date
dc.date.accessioned
2019-03-15T16:03:41Z
Available date
dc.date.available
2019-03-15T16:03:41Z
Publication date
dc.date.issued
2013
Cita de ítem
dc.identifier.citation
Arthritis and Rheumatism, Volumen 65, Issue 1, 2018, Pages 120-129
Identifier
dc.identifier.issn
00043591
Identifier
dc.identifier.issn
15290131
Identifier
dc.identifier.other
10.1002/art.37702
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165888
Abstract
dc.description.abstract
Objective Dendritic cells (DCs) modulated with lipopolysaccharide (LPS) are able to reduce inflammation when therapeutically administered into mice with collagen-induced arthritis (CIA). The aim of this study was to uncover the mechanisms that define the tolerogenic effect of short-term LPS-modulated DCs on CIA. Methods Bone marrow-derived DCs were stimulated for 4 hours with LPS and characterized for their expression of maturation markers and their cytokine secretion profiles. Stimulated cells were treated with SB203580 or SB431542 to inhibit the p38 or transforming growth factor β (TGFβ) receptor pathway, respectively, or were left unmodified and, on day 35 after CIA induction, were used to inoculate mice. Disease severity was evaluated clinically. CD4+ T cell populations were counted in the spleen and lymph nodes from inoculated or untreated mice with CIA. CD4+ splenic T cells were transferred from mice with CIA treated with LPS-stimulated DCs or from untreated mice with CIA into ot